Cold Chain Storage & Distribution Europe

A choice of interactive roundtable discussions on all the most challenging issues!

Achieve control throughout your cold chain processes and ensure full compliance with current and upcoming regulations

7th Annual

Cold Chain Storage and Distribution

REGISTER NoW:■ online: www.coldchain-events.com ■ Email: [email protected]■ Tel: +44 (0)20 7753 4268 ■ Fax: +44 (0) 20 7915 9773

DISTINGuISHED SPEAKERS INCLuDE:Viliam Kovac, Vice President Quality and Divisional Export Control, RoCHE DIAGNoSTICS

Fabio Mioli, Senior Manager, Commercial Offi ce and Distribution, WYETH PHARMACEuTICALS/PFIZER

Bert janssen, Manager QA Supply Chain, Quality Assurance Pharmaceutical, Operations Beerse, Janssen Pharmaceutica, joHNSoN & joHNSoN

Maria Dorazio, EMEA Distribution Manager, BRISToL-MYERS SQuIBB

Angelique Keijzer, Clinical Support Manager, SANoFI-AVENTIS

Eric Delestre, Marketing Affi liates Quality Assurance Associate, ELI LILLY

Maurizio Caschera, GDP Responsible & Regulatory Aff airs Executive, SANoFI PASTEuR MSD

Ilona Zwernemann, Manager ADM and GMP Logistics, BAYER HEALTHCARE

Michael Krahe, Manager Cold Chain Operations/Logistics, BAYER HEALTHCARE

Saddam Huq, Cold Chain Technology Lead, WYETH PHARMACEuTICALS/PFIZER

Cornelia Nopitsch-Mai, Scientist, Federal Institute for Drugs and Medical Devices Germany, BfArM

Ian Holloway, Manager, Defective Medicines Reporting Centre, MHRA

ENGAGE WITH INDuSTRY LEADERS INCLuDING:

VIBpharma

BRAND NEW CASE STuDIES THIS YEAR WILL uNCoVER:

How to overcome the challenge of keeping the •temperature stable for 2-8°C and frozen shipments

Techniques for making the right cold chain decisions •early to optimise your supply chain processes

Why conducting a risk assessment is a crucial part •of your validation in guaranteeing a safe cold chain process from start to fi nish

Current regulatory trends in ambient temperature •control and how to implement auditing systems cost-eff ectively

MHRA•joHNSoN & joHNSoN•ELI LILLY•SANoFI-AVENTIS•

BRISToL-MYERS SQuIBB•RoCHE DIAGNoSTICS•WYETH/PFIZER•BFARM•

Tuesday 23 and Wednesday 24 February 2010, London, UK • www.coldchain-events.com

BRAND NEW CASE STuDIES THIS

Tuesday 23 and Wednesday 24 February 2010, London, UK • www.coldchain-events.comCo-located with our 11th Annual Clinical Trial Supply conference

Gold Sponsor: Silver Sponsors:

Organised by:

Programme Day One Tuesday 23 February 2010

Organised by:

chain management is transferred from the manufacturer to the customer and assessing the potential risk for a manufacturer if the cold chain is not respected by the customer Outlining the main actions a manufacturer can implement ●

in order to mitigate the risk on his product Maurizio Caschera, GDP Responsible &

Regulatory Affairs Executive, SANoFI PASTEuR MSD

10:30 Morning refreshments

11:15 overcoming cold chain challenges when distributing to emerging countries highlighting operational and regulatory solutions to be implementedQualifying potential routes in countries with less ●

established infrastructure: outlining potential alternatives that ensure safe cold chain distributionAssessing related risks and picturing scenarios to tackle ●

them effectivelyIdentifying best qualified 3rd parties for various types of ●

shipments and understanding how to cooperate with them successfullyUnderstanding local regulations and evaluating whether ●

further safety measures need to be implemented to minimise risk Implementing an appropriate quality system to optimise ●

the distribution process on a non-qualified routeRoger Price, Director Business Development, ClinStar, IMP LoGISTICS

11:45 Moving towards a global cold chain: entering new countries whilst finding reliable local service providers and complying with international regulationsAssessing the infrastructure of the destination country in ●

terms of routes, storage facilities and customers available as well as related risksDebating how to find the right couriers for small and large ●

quantities and how to manage them successfully: executing audits and using reliable monitoring systemsUncovering how to manage the distribution process on a ●

non-qualified route whilst minimising riskUnderstanding local regulations and practices in order to ●

validate packaging and cooling systems and qualify 3rd parties accordinglyImplementing a simple quality system that ensures process ●

safety and control as well as integrity of the productRobert Arendal, Chairman, CooL CHAIN ASSoCIATIoN

12:15 Clarifying current and upcoming international cold chain regulations and how to implement them effectively in order to ensure full complianceOutlining national and GDP (Good Distribution Practice) ●

regulations and guidelines relevant to cold chain equipment and processes Exploring European requirements regarding stability data of ●

products requiring cold chain storageHighlighting the ongoing discussion on the European field ●

regarding transport conditionsClarifying stability issues of pharmaceutical bulk products ●

and assessing how to overcome them Cornelia Nopitsch-Mai, Scientist, Federal Institute for Drugs and Medical Devices Germany, BFARM

12:45 Lunch

08:30 Registration and coffee

08:55 opening remarks from the Chair

Qualifying cold chain shipments while validating components and performance through continuous monitoring09:00 Conducting qualification studies of ambient

temperature shipping packages and systems in order to comply with global standards and giving a regulatory updateClarifying the key regulatory requirements on ambient ●

temperature controlAdvising pharma and biotech companies for developing an ●

effective global ambient temperature strategy Setting up a thermal mapping on ambient and trailer •

conditions to identify which temperature extremes the shipping is exposed to

Utilising temperature profiles typical for the type •

of packaging used to assess the period of time the temperature is kept on constant

Establishing if passive and/or active cooling systems are •

needed based on the ambient temperature the shipping will be facing

Ensuring appropriate handling of the product through logistics ●

solutions providers by clarifying responsibilities in order to guarantee the product quality is kept on a high standardEstablishing appropriate quality check and auditing systems ●

for your own cold chain structureIan Holloway, Manager, Defective Medicines Reporting Centre, MHRA

09:30 Carrying out a risk assessment as a crucial part of the validation process and driving factor of costs to guarantee a safe cold chainExecuting stability studies and evaluating stability data of ●

products to be shipped and storedEstablishing risk factors in connection with all components ●

involved such as packaging, shipping trailers and storage facilitiesAssessing the risk to be considered with regards to ●

operations and handling of products such as number and duration of stop-oversRating all factors and identifying how to handle the risks ●

that need to be faced effectivelyBalancing risk and cost based on the determination of ●

safety margins in order to ensure a smooth cold chain process within budgetViliam Kovac, Vice President Global Quality and Divisional Export Control, RoCHE DIAGNoSTICS

Going global: how to enter new markets, comply with regulations and overcome operational challenges10:00 Debating the difficulty of making sure that your

product arrives in the right condition and outlining the possibilities to ensure the cold chain until product administrationPresenting a case study on the administration of a ●

medicinal product by the doctor: how to ensure a successful standardised cold chain management from your warehouse to the administration of the product to the patientComparing the regulatory requirements for manufacturers, ●

distributors, wholesalers and pharmacists regarding storage and distribution: outlining guidelines on Good Distribution Practice (GDP) defined by WHO and national regulatory bodies such as the Irish Medicines Board Debating at what stage the responsibility for the cold ●

Programme Day One

08:30 Registration and coffee

08:55 Opening remarks from the Chair

Controlling cold chain processes effectively to ensure product safety and integrity09:00 Case study: outlining the key elements of temperature

and quality management and how these contribute successfully to your overall distribution strategyIdentifying what a pharmaceutical company aims for in terms ●

of successful temperature management in accordance to current regulationsHighlighting which solutions are in place by temperature ●

control solution providers and exploring future trends to optimise the outcomeLearning how to ensure effective quality management by ●

Developing internal cold chain guidelines and updating •

quality agreements Establishing detailed cold chain documentation according •

to regulatory requirements Auditing cold chain capabilities and qualifying shipping •

lanes and road and air transportation equipmentUncovering how to implement these successfully in your ●

overall distribution process map and distribution strategyMaria Dorazio, EMEA Distribution Manager, BRISToL-MYERS SQuIBB

09:30 overcoming challenges related to the control of frozen shipments and uncovering solutions to validate reliable freezers and qualify shippersPresenting regulatory developments and trends with respect to ●

frozen shipments in Europe Finding the right technology or solution provider who is able to ●

develop a freezer system that matches your needsEstablishing ways to validate your packaging and freezing ●

devices successfully in order to ensure integrity of your products at all timesQualifying shippers that are able to guarantee safe handling ●

and deliveryAnalysing defrost cycles of the products in order to establish ●

when the product quality is jeopardized in case of failure of the cooling systemIdentifying approaches to remedy the breakdown of a ●

freezing system to ensure the temperature is kept within the required limitMarc Weinzweig, QP (Qualified Person) and Founder, BIoTEC

10:00 Case study: Dealing with temperature excursion successfully in a challenging environmentAddressing the Italian logistics system to explore and ●

understand characteristics and challenges Outlining temperature excursion risks and potential issues for ●

biotech drugs and vaccines Explaining selected systems and solutions to ensure the ●

maximum safety level Debating the trends of cold chain logistics and exploring new ●

solutions of some of the main players Fabio Mioli, Senior Manager Commercial office and Distribution, WYETH PHARMACEuTICALS/PFIZER

10:30 Morning refreshments

11:15 Implementing cold chain controls from manufacturing to distribution for cold chain pharma productsUnderstanding national and international regulations on ●

temperature requirements in terms of ambient, 2-8°C or dry ice shipmentsEvaluating acceptable excursions based on stability data ●

Assessing distribution and production scenarios from the ●

manufacturing site to the last mile

Programme Day Two14:15 RouNDTABLE AFTERNooN SESSIoNS

Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to a current aspect of cold chain storage and distribution. A 45 minute afternoon refreshment break will take place after the first roundtable session.

Roundtable 1: Identifying and managing risk in cold chain shipping by assessing clear actions to be taken in case of jeopardized process safetyEstablishing and evaluating risk factors throughout all stages of cold chain and balancing risks while keeping processes aligned with determined safety marginsSue Lee, Manager, BioPharm Systems, Research and Development, WoRLD CouRIER

Roundtable 2: Assessing current regulatory trends with respect to monitoring ambient temperature shipments and how to implement a monitoring system cost-effectivelyClarifying upcoming guidelines to establish a strategy on how to monitor ambient temperature shipments effectively, in compliance with new standards and with minimal cost involvedWim van Bon, President, European Cold Storage and Logistics Association, ECSLA

Roundtable 3: Debating the difficulty of making sure that your product arrives in the right condition when administered to the patientDiscussing at what stage the responsibility for cold chain management is transferred from the manufacturer to the customer and assessing the potential risk for a manufacturer if the cold chain is not respected by the customerMaurizio Caschera, GDP Responsible & Regulatory Affairs Executive, SANoFI PASTEuR MSD

Roundtable 4: Identifying alternative means and ways of cold chain distribution while keeping the required quality standardsEvaluating alternative solutions including new distribution channels while keeping your distribution processes flexible and efficient Ilona Zwernemann, Manager ADM and GMP Logistics, BAYER HEALTHCARE

Michael Krahe, Manager Cold Chain operations/Logistics, BAYER HEALTHCARE

18:00 Closing remarks from the Chair and end of day one

Programme Day Two Wednesday 24 February 2010

Identifying the risks and challenges on each distribution level ●

and establishing strategies to overcome them cost-effectivelyImplementing lean documentation practices to support the ●

quality of the productChecking that all shippers are well informed about product ●

handling requirements and implementing a monitoring system to ensure product safetyBert janssen, Manager QA Supply Chain, Quality Assurance Pharmaceutical, operations Beerse, janssen Pharmaceutica, joHNSoN & joHNSoN

uncovering techniques for making the right cold chain decisions early to optimise the process11:45 Managing cold chain and ambient storage facilities to

actively preserve valuable suppliesElectronic vs. mechanical temperature monitors: which ●

perform best? Assessing how to implement adequate temperature ●

monitoring in a study site Outlining best practice temperature control methods: ●

ambient and temperature specific product distribution Managing deviation and guaranteeing your product stability ●

through comprehensive temperature control and monitoring strategies Angelique Keijzer, Clinical Support Manager, SANoFI-AVENTIS

12:15 Lunch

13:45 outlining the cold chain distribution of medical samples: what are options, challenges and how to overcome themPresenting the different existing options for the distribution ●

of medical samplesClarifying the regulatory requirements and how to ●

ensure compliance Describing options of storage and assessing the pros and cons ●

Exploring current ways of transportation and addressing ●

issues faced Explaining the equipment used ●

Clarifying which parts of the process can be qualified and ●

how to achieve full qualificationIdentifying how to optimise the process by quality ●

issues managementEric Delestre, Marketing Affiliates Quality Assurance Associate, ELI LILLY

14:15 Presenting strategies to plan cold chain storage effectively and establishing approaches to make storage activities cost-efficientEvaluating storage in centralised vs. decentralised supply chain ●

systems in order to find the best solution for your cold chain distributionPlanning the storage process: using a reduced number of ●

distribution centres as a result of consolidation activitiesKeeping your storage planning flexible to avoid shortage of ●

spaceAssessing the number, service range and quality of local ●

contractors to establish whether all product handling requirements can be met cost-effectivelyDeveloping approaches to make the entire storage process more ●

cost-efficientManaging internal and external warehouses and staff effectively: ●

actions to be taken and checklists to be usedWim van Bon, President, European Cold Storage and Logistics Association, ECSLA

14:45 Reviewing airfreight shipment of cold chain products using PAG shippersIdentifying the system design and temperature ●

specification of the productAssessing shipping lanes and routes to be considered ●

and how to qualify them Exploring the challenges to keep the temperature stable ●

within the specification of 2-8°C and how to overcome themOutlining the options of green credentials for cold chain ●

products and how to secure themSaddam Huq, Cold Chain Technology Lead, WYETH PHARMACEuTICALS/PFIZER

15:15 Closing remarks from the Chair and close of the conference

Gold Sponsor:

World Courier handles approximately 80% of the clinical trials market worldwide requiring a premium courier service. Specialists in packaging and airfreight

qualification, compliance and dangerous goods, operating Best Practice in temperature sensitive pharmaceuticals 24x7x365 service; all shipments leave on next-flight-out; all packing materials to UN specifications; real-time web tracking and email alerts; ISO 9001 certification worldwide www.worldcourier.com

PAREXEL International is a leading global bio/pharmaceutical services organization offering

significant expertise from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. This expertise is enhanced by industry-leading technology solutions from its Perceptive Informatics division through medical imaging, CTMS, IVRS/IWRS and integration services. www.parexel.com

Silver Sponsors:Almac offers an integrated supply chain management solution that draws on the expertise of its best in class clinical trial supplies and IVR/web based services. Its

integrated solution does more than just combine related services under one roof; it incorporates supply planning, technology implementation, and project oversight into a unified study start-up and management approach that optimises the supply chain at each level. Almac and its affiliated companies provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, API manufacturing, clinical trials and drug manufacturing. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh. www.almacgroup.com

Penn Pharma is a leading provider of integrated product development and custom manufacturing services to the international healthcare industry including formulation

and analytical development, clinical trial supply, custom manufacture, high containment processing, CMC consultancy and QP release services. Penn manufactures to GMP and is MHRA licensed and FDA inspected. www.pennpharm.co.uk

Piramal Healthcare is at the forefront of custom manufacturing for the Pharmaceutical Industry. Our capabilities extend across the high quality development

and manufacture of API, Formulations and Clinical Trial Materials. Our global network of services integrated across the drug life cycle, offers a unique blend of flexibility and efficiency as your CMO partner of choice. www.piramalpharmasolutions.com

MWV Healthcare Packaging is working with you to turn your objectives for quality,

performance and visual impact into one-of-a-kind packaging that really stands out for patients. Their packaging promotes adherence and health literacy, while making products childproof and tamper resistant, senior-friendly, traceable and compliant for the clinical trial, OTC and ethical drug markets. www.MWV.com

Biotec is a UK based Clinical Trials Supply company focusing on the import, Qualified Person certification, labelling, assembly, storage and world-wide distribution

of clinical trial supplies for Phase I to IV trials, through to commercial supplies. We specialise in handling temperature sensitive biopharmaceuticals from controlled ambient conditions to 2-8°C, -20°C and -80°C. www.biotec-uk.com

Yourway Transport has set the standard for quickness, dependability and personalized service within the transportation industry. Today speed of delivery is no longer the only consideration. Temperature control, specialized packaging, multicentre coordination, just-

in-time logistical supply chain solutions, enhanced computer and information requirements are also of vital importance. Our ongoing commitment is to earn the trust and confidence of our customers by providing consistent, reliable service and communication. Combine our years of operational experience with some of the best information systems in the industry and it’s easy to see why Yourway Transport continues to be the market leader. www.yourwaytransport.com

Tourtellotte Solutions produces leading applications for the pharmaceutical industry – tcVisualize for clinical supply simulation - Fusion for document processes -

Trident for next generation IWR, - and builds custom enterprise solutions for Fortune 500 companies worldwide. www.tourtellottesolutions.com

Multi Pharma offer worldwide comparator drug sourcing for clinical trials. With facilities in Switzerland, Germany and New Jersey we fulfill needs of single lot, long expiration date, Certificate of Analysis, Material Safety Data Sheet,

GMP Certificate, samples, etc. We have the capacity and experience to supply large amounts fast directly from the manufacturer. www.multipharma.ch

Phase Forward is a leading provider of integrated data management solutions for

clinical trials and drug safety. The company offers proven solutions for electronic data capture (InFormTM), phase I clinic automation (LabPasTM), clinical data management (ClintrialTM), clinical trials signal detection (CTSDTM), strategic pharmacovigilance (Empirica SignalTM) and Signal Management, adverse event reporting (Empirica TraceTM), applied data standards (WebSDMTM) and Web-integrated interactive response technology (Clarix™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Additional information about Phase Forward is available at www.phaseforward.com.

IMP Logistics’ core business is investigational medical products and clinical materials

warehousing, distribution, import licensing and customs clearance. IMP Logistics is focused on clinical trials and because of this specialization its reputation and business has grown rapidly in recent years. IMP Logistics is now established as the leading facility of its type in Russia and Ukraine. www.imp-log.com

Schreiner MediPharm is a leader in the development and manufacture of innovative specialty labels with value-added benefits. These products simplify

dispensing and administering of pharmaceuticals, enhance drug safety and clearly reduce process costs. As a long-standing expert partner of the pharmaceutical industry, Schreiner MediPharm offers a range of customized products and services specifically addressing the complexity of clinical trials. www.schreiner-medipharm.com

Durbin text - Durbin is a specialist provider of comparator drugs for clinical trials. In addition to comparator drugs, Durbin also provides

ancillary supplies and placebos. Durbin brings global sourcing expertise,transparent pricing and global custom distribution to the supply of comparators and ancillaries for clinical trials. www.durbin.co.uk

Clintrak Clinical Labeling Services, LLC. Is the industry leader in providing innovative clinical labeling solutions. Clintrak manufactures single panel labels, multi-panel labels, multi-language booklet labels,

case report forms and blinding/code break cards. Our in-house printing capability, exclusive translation/regulatory approval system and expertise in clinical label design will streamline the label segment of yourtrials. Last year alone, Clintrak produced over 20 million labels for clinical trials use! Clintrak is a member of Fisher BioPharma Services Division and Thermo Fisher Scientific. www.clintrak.com

Exhibitors:

GE Sensing & Inspection Technologies

Media Partners:

World Pharmaceutical Frontiers www.worldpharmaceuticals.net

Booking Form 7th Annual Cold Chain Storage and Distribution Tuesday 23 and Wednesday 24 February 2010, London, UK

■ I enclose a cheque drawn on a UK bank (please make cheque payable to VIBevents and write reference CCSD0210 on the reverse)

■ I will transfer payment to your Lloyds TSB account City Branch, London, UK: 01492549, sort code 30-00-02 (using reference CCSD0210)

■ I would like to pay with my credit card ■ Visa ■ Mastercard ■ AMEX ■ Maestro ■ Solo

Card Number: Expiry Date: Issue Date: CSV*:

Cardholder's Name:

Cardholder's Address:

*The CSV number is the last 3 digit number on the reverse of the card

■ Yes, I have read and understood the terms and cancellations conditions and am happy to proceed with my registration

Signature Date

Delegate Details please photocopy form for multiple bookings

Mr/Mrs/Ms/Dr: First Name: Surname:

Email: Tel: Job Title:

Fax: Department:

Company Details

Company: Address:

Town: Postcode: Country:

VAT Number: Nature of Business:

Payment Details

Purchase Order No.

Venue DetailsThe two day conference will take place on Tuesday 23 and Wednesday 24 February 2010. The venue will be a centrally located hotel in London, UK. For further information contact our Operations department on +44 (o) 207 753 4201.

Are you registered?You will always receive an acknowledgement of your booking. If you do not receive anything, please call us on +44 (0) 20 7753 4268 to make sure we have received your booking.

ALL ToTAL FEES ARE SuBjECT To A 2.5% SERVICE CHARGE

Total Discount code if applicable _________________________________Discounts are at the discretion of VIBevents and are not cumulative

Four Easy Ways To Book: ■ Register online at

■ Email us at [email protected]

■ Tel +44 (0)20 7753 4268

■ Fax +44 (0)20 7915 9773

Prices & Payment Information (please tick option)

Vibpharma Conference Delegate terms and conditions1. Scope of Agreement: These are the conditions of the contract between you, the Client (“You” and “your”) and Vibpharma (“Vibpharma”, “we”, “us” and “our”) governing your use of our services, including the conference registration as set out in your booking form. This agreement constitutes the entire agreement between Vibpharma and you. All prior agreements understandings and negotiations and representations (save for fraudulent misrepresentation) whether oral or in writing are cancelled in their entirety. The terms of any other electronic communications will not form part of this agreement.2. Our commitment to you: Should the Event be cancelled or the location be changed for reasons or circumstances beyond our control, we reserve the right to reschedule the Event, including changing the location, upon written notice to you. Should the event fail to be rescheduled for any reason your refund shall not exceed the total charge received by us from you.3. Payment Terms: The Total Fees specified on the booking form are subject to an additional service charge of 2.5% (“Service Charge”) applied to cover administration costs, and are exclusive of VAT and any other applicable sales tax which shall be payable in addition.• Following completion and return of the booking form, full payment including Service Charge is required within five days from the invoice date or prior to the event if this is sooner. All registrants must provide a credit card number as a guarantee at the time of booking. We reserve the right to charge your card in full if payment is not received in accordance with these payment terms. We reserve the right to refuse admission if full payment is not received in accordance with these terms.

• If you are a Biotech/Pharma Manufacturer and have signed up as a free of charge delegate, you will incur a charge of $499 if you cancel your registration.4. General: You, your executive/s or your agents may not transfer or assign any of the rights or obligations of this Agreement (in whole or part) without our prior consent. Any attempt to resell, assign or transfer rights without our consent will entitle us to cancel the contract without liability to you.• This agreement is governed by and will be construed in accordance with English law and each party irrevocably agrees that the courts of England will have the non-exclusive jurisdiction to deal with any disputes arising out of or in connection with this agreement.• Vibpharma is subject to the UK Data Protection Act 1998 and is registered in the UK with the Information Commissioner to process your personal information. Our primary goal in collecting personal information from you is to give you an enjoyable customised experience whilst allowing us to provide services and features that most likely meet your needs. We collect certain personal information from you, which you give to us when using our Sites and/or registering or subscribing for our products and services. We also collect certain personal data from other group companies to whom you have given information through their websites. The information provided will be held on our database and may be shared with other companies within the same Group. Occasionally your details may be made available to our external partners. If you do not want us to continue using this information please notify us at [email protected]• The working language of the Event is English. Executives requiring an interpretation service must make their own arrangements at their own expense.

Arena International Events Group, a trading division of SPG Media Ltd. Registered Offi ce: 55 North Wharf Road, London, W2 1LA, UK. Registered in England No. 01155599. www.arena-international.com

Yes, I would like to register for the event: BEFoRE25.11.2009

BEFoRE23.12.2009

BEFoRE20.01.2010

AFTER20.01.2010

Pharma manufacturers and Biotechs

I would like the VIP attendees package to include the two day conference + interactive CD-ROM (saving €70)

€2450 (VAT where applicable)




I would like to attend the two day conference only €1820+VAT@ 17.5% = €2138.50

€1960+VAT@ 17.5% =€2303.00

€2100+VAT@ 17.5% =€2467.50

€2310+VAT@ 17.5% =€2714.25

Academic/Government representatives






I would like to attend the two day conference only €910+VAT@ 17.5% =€1069.25

€1050+VAT@ 17.5% =€1233.75

€1190+VAT@ 17.5% =€1398.25

€1400+VAT@ 17.5% =€1645.00

Fee for other participants (Non Pharma Manufacturers/Biotechs)






I would like to attend the two day conference only €2820+VAT@ 17.5% =€3313.50

€2960+VAT@ 17.5% =€3478.00

€3100+VAT@ 17.5% =€3642.50

€3310+VAT@ 17.5% =€3889.25

All participants

I cannot attend the conference but would like to receive the interactive CD ROM





Health & Medicine

Cold Chain Storage & Distribution Europe